Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination. Aug 2010 - Proc. Natl. Acad. Sci. U.S.A.; 107(31):1091-6490 [PMID:20631300] [Van Tendeloo VF] [Van de Velde A] [Van Driessche A] [Cools N] [Anguille S] [Ladell K] [Gostick E] [Vermeulen K] [Pieters K] [Nijs G] [Stein B] [Smits EL] [Schroyens WA] [Gadisseur AP] [Vrelust I] [Jorens PG] [Goossens H] [de Vries IJ] [Price DA] [Oji Y] [Oka Y] [Sugiyama H] [Berneman ZN]
Dendritic cell-based cancer gene therapy. Oct 2009 - Hum. Gene Ther.; 20(10):1557-7422 [PMID:19656053] [Smits EL] [Anguille S] [Cools N] [Berneman ZN] [Van Tendeloo VF]
Immunotherapy of acute myeloid leukemia: current approaches. Apr 2009 - Oncologist; 14(3):1549-490X [PMID:19289488] [Smits EL] [Berneman ZN] [Van Tendeloo VF]
